Sonoma Pharmaceuticals, Inc.
SNOA • NASDAQ
Sonoma Pharmaceuticals, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Amy Trombly, with a market cap of $3.7M.
CEOAmy Trombly
Market Cap$3.7M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees171.0
Websitesonomapharma.com
Next Earnings
Upcoming earnings announcement for Sonoma Pharmaceuticals, Inc.
Date
Tuesday, June 16, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q4 2026
EPS Estimate
-$0.24
Revenue Estimate
$5.6M
Earnings History
Past 12 earnings reports for Sonoma Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q3 2026 | -$0.48Est: -$0.31 | -54.8% | $4.3MEst: $4.3M | +0.4% |  10-Q |
| Nov 4, 2025 | Q2 2026 | -$0.32Est: -$0.31 | -3.2% | $5.6MEst: $4.3M | +31.5% | 10-Q |
| Aug 7, 2025 | Q1 2026 | -$0.76 | — | $4.0MEst: $4.1M | -0.9% | 10-Q |
| Jun 17, 2025 | Q4 2025 | -$0.48Est: -$0.60 | +20.0% | $3.8MEst: $4.4M | -15.5% | 10-K |
| Feb 5, 2025 | Q3 2025 | -$0.63Est: -$0.60 | -5.0% | $3.6MEst: $4.1M | -12.2% | 10-Q |
| Nov 7, 2024 | Q2 2025 | -$0.59Est: -$1.00 | +41.0% | $3.6MEst: $4.0M | -10.1% | 10-Q |
| Aug 8, 2024 | Q1 2025 | -$1.40Est: -$1.20 | -16.7% | $3.4MEst: $3.9M | -13.9% | 10-Q |
| Jun 17, 2024 | Q4 2024 | -$1.40 | — | $3.4MEst: $4.0M | -13.6% | 10-K |
| Feb 8, 2024 | Q3 2024 | -$1.60 | — | $3.1M | — | 10-Q |
| Nov 13, 2023 | Q2 2024 | -$5.80Est: -$4.80 | -20.8% | $2.7MEst: $3.5M | -21.5% | — |
| Aug 10, 2023 | Q1 2024 | -$5.80 | — | $3.4M | — | 10-Q |
| Jun 22, 2023 | Q4 2023 | -$6.20 | — | $3.0M | — | — |